LindseyMarieLylePA

PubMed

• 13 citations
  Current and emerging therapies for patients with acute myeloid leukemia: a focus on MCL-1 and the CDK9 pathway.
  Lindsey Lyle, Naval Daver
  The American Journal of Managed Care. 2018-08-01
• 11 citations
  Iron Overload in Myelodysplastic Syndromes: Pathophysiology, Consequences, Diagnosis, and Treatment.
  Lindsey Lyle, Alex Hirose
  Journal of the Advanced Practitioner in Oncology. 2018-05-01

Journal Articles

• Novel Hematological Parameters for the Evaluation of Patients with Myeloproliferative Neoplasms: the Immature Platelet and Reticulocyte Fractions  
  Paolo Strati, Prithviraj Bose, Lindsey Lyle, Katie Gaw, Lingsha Zhou, Sherry A Pierce, Julie Huynh-Lu, Cheryl F. Hirsch-Ginsberg, Daniel E. Bueso-Mendoza, Carlos E Bue..., Ann Hematol, 1/1/2017
• PTP: The Older Adult Living with CLL: Implications for Oncology Providers, Patients and Caregivers  
  Lyle L, Journal of the Advanced Practitioner in Oncology, 1/1/2017
• Practical Strategies for Management of Lenalidomide-Associated Cytopenias in Myelodysplastic Syndromes With del(5q)  
  Lyle L, Journal of the Advanced Practitioner in Oncology, 1/1/2016
• The Role of Advanced Practitioners in Optimizing Clinical Management and Support of Patients with Polycythemia Vera  
  Lyle L, Kurtin S, Journal of the Advanced Practitioner in Oncology
• Join now to see all

Lectures

• Differentiation syndrome in the setting of IDH2 inhibition: Case Study 
  1/1/2017
• Acute Leukemia Disease State Education 
  1/1/2017
• Hydration and Electrolyte Imbalance in Hematopoietic Stem Cell Transplant 
  1/1/2017
• Hematology for Nurse Practitioners and Physician Assistants: Focus on Polycythemia Vera 
  1/1/2017
• Myelofibrosis and Polycythemia Vera: JAK-inhibition and Beyond 
  1/1/2016
• MPN Awareness Month Program: Patient Power 
  1/1/2016
• Updates in Myeloproliferative Neoplasms 
  1/1/2016
• “Blood Cells Gone Bad” Review of Myelodysplastic Syndrome, Polycythemia Vera, Factor Deficiencies, and Heparin Induced Thrombocytopenia in the patient with Chronic Kid... 
  1/28/2015
• Role of JAK inhibition in Myelofibrosis and Polycythemia Vera 
  1/1/2015
• JAK Inhibitors for Myelofibrosis 
  1/1/2015
• Blood Products 
  1/1/2015
• ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant 
  1/23/2014
• RESPONSE Trial Patient Cases, Ruxolitinib in refractory or intolerant Polycythemia Vera Patients 
  1/1/2014
• Understanding the role of a Physician Assistant: Management of patients with hematologic malignancies 
  1/1/2014
• Living Well with Myeloproliferative Neoplasms (MPNs) 
  1/1/2014
• JNC 8: Evidence Based Guidelines for the management of high blood pressure in adults 
  1/1/2014
• APSHO Skills Workshop: Multiple Myeloma CME curriculum development 
• Join now to see all

Other

• Development of curriculum for AAPA CME credit 
  Lyle L, Kurtin S, APSHO boot camps: Focus on Multiple Myeloma
  1/1/2016